Profile

Cover photo
24 followers|12,478 views
AboutPostsPhotosVideos

Stream

Westwicke Partners

Shared publicly  - 
 
Here’s our guidance on how often you should update your IR presentation deck, and who should be involved in the process. http://bit.ly/2bxpznm
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Here’s how to expand the number of sell-side analysts covering your company. The first step is to know that it’s a process. http://bit.ly/2aNmHVR
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Investors bearish on biotech despite 2016’s median pre-money IPO valuation being 30 percent higher than the ‘13–‘14 boom: http://bit.ly/2a3PK8e
After five very strong years, biotech as a sector has struggled to catalyze positive investor sentiment so far for the past 12 months. In a disastrous start to the year, the NASDAQ Biotech Index shed 30% in just the first 40 days. The carnage of this winter’s market was captured [...]
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Product differentiation, among other challenges, will be tricky for startups with all eyes on the same cancer-immunotherapy prize in this I/O gold rush. What do you think? http://bit.ly/29ezBa9
With the big cancer confab ASCO 2016 fading into memory, R&D teams everywhere are getting back to work on their cancer programs – and across the industry many of them will be doing the same work, on the same targets,
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Analysts are concerned about the outlook for biotech and pharmaceutical sector companies, as factors ranging from domestic politics to global economic uncertainty cloud the future, according to Pharm Exec. What do you think? http://bit.ly/1UiikS8
Do recent trends in the pharma and biotech M&A and equity markets signal a temporary lull — or a permanent drop? Peter Young reports.
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Here are some things to keep in mind when developing your guidance to investors. Remember, missing guidance in just one quarter can be disastrous. http://bit.ly/1swbZYQ
1
Add a comment...
Have them in circles
24 people
mohammad nami's profile photo
Jeff Mirkin's profile photo
Jamie Reed's profile photo
Christine Guenther's profile photo
Right Source Marketing's profile photo
Bharat Book Bureau 3B's profile photo
Lihtec Funding's profile photo
JSB Marketresearch's profile photo
Steel Rose Communications's profile photo

Westwicke Partners

Shared publicly  - 
 
If market conditions force a delay in your planned IPO, you might as well make the most of the extra time. Here are five ideas for doing that. http://bit.ly/2bfDHpt
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
You may have heard that the SEC has issued new guidance on regulations governing the reporting of non-GAAP financial measures. It’s important you understand the rules, so we have a detailed explanation. http://bit.ly/29Ut0sd
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Management credibility is essential if you’re going to have a positive relationship with your investors. So you how do you build yours? Start here. http://bit.ly/29Oy6UH
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Need an investment bank? You’ll likely be presented plenty of so-called league tables. But to find the right bank for you, you’ll want to go deeper. Here are five factors to consider. http://bit.ly/29ibjfH
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Biotech companies are valued differently than those in other industries, and that makes biotech IR unique. Here’s what you need to know. http://bit.ly/1Ope82u
1
Add a comment...

Westwicke Partners

Shared publicly  - 
 
Specializing in med tech and diagnostics in our San Francisco office, Caroline Corner, Ph.D., is the newest member of the Westwicke Partners family. Welcome, Caroline. http://bit.ly/1UAlTPb
1
Add a comment...
People
Have them in circles
24 people
mohammad nami's profile photo
Jeff Mirkin's profile photo
Jamie Reed's profile photo
Christine Guenther's profile photo
Right Source Marketing's profile photo
Bharat Book Bureau 3B's profile photo
Lihtec Funding's profile photo
JSB Marketresearch's profile photo
Steel Rose Communications's profile photo
Contact Information
Contact info
Phone
(443) 213-0500
Email
Story
Tagline
Strategic Investor Relations and Independent Capital Markets Advice
Introduction
Westwicke Partners provides customized investor relations programs and independent capital markets advice to both public and private healthcare companies.